Liver Transplantation for Monogenic Metabolic Diseases Involving the Kidney
Several metabolic monogenic diseases may be cured by liver transplantation alone (LTA) or by combined liver–kidney transplantation (CLKT) when the metabolic disease has caused end-stage renal disease. Liver transplantation may be regarded as a substitute for an injured liver or as supplying a tissu...
Main Authors: | Maurizio Salvadori, Aris Tsalouchos |
---|---|
Format: | Article |
Language: | English |
Published: |
Codon Publications
2017-07-01
|
Series: | Journal of Renal and Hepatic Disorders |
Subjects: | |
Online Access: | https://jrenhep.com/index.php/jrenhep/article/view/18 |
Similar Items
-
Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome– a single center experience
by: Sam Kant, et al.
Published: (2020-05-01) -
Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis
by: Maria L. Gonzalez Suarez, et al.
Published: (2019-06-01) -
Successful Renal Transplantation in a Patient with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab in China
by: Ze-Jia Sun, et al.
Published: (2016-01-01) -
Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease
by: E. I. Prokopenko, et al.
Published: (2020-07-01) -
Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report
by: Suk-Hee Park, et al.
Published: (2014-06-01)